Is Desmopressin legal in the US?
Yes, FDA approved for diabetes insipidus, some bleeding disorders, bedwetting and night-time urination.
Desmopressin is FDA-approved, first in 1978 as DDAVP, for central diabetes insipidus, for temporary excessive urination after pituitary surgery or head injury, for bleeding control in mild hemophilia A and type 1 von Willebrand disease, and for primary nocturnal enuresis (bedwetting) in children; Nocdurna, a sublingual tablet approved in 2018, treats nocturia due to nocturnal polyuria in adults. The Noctiva nasal spray approved in 2017 for nocturia has been discontinued, and the Stimate nasal spray for bleeding disorders was recalled in 2020 and was still off the market in 2023. 2314
Yes, since 1978. Approved uses include central diabetes insipidus, post-surgical polyuria, mild hemophilia A, type 1 von Willebrand disease and childhood bedwetting. The Nocdurna tablet is approved for adult nocturia. 23
Read the full Desmopressin page
More on Desmopressin
Citations
- Drugs.com: Noctiva (desmopressin nasal spray), discontinued drugs.com
- DDAVP (desmopressin acetate) prescribing information drugs.com
- Nocdurna (desmopressin acetate sublingual tablets) prescribing information drugs.com
- National Bleeding Disorders Foundation: updates on the desmopressin nasal spray recall bleeding.org
Reference information only, not medical advice. Drawn from the Desmopressin article, fact-checked against the cited sources. No dosing anywhere on this site.